|
1）Ju BG, Lunyak VV, Perissi V, et al. A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Science. 2006; 312: 1798-802
|
|
|
|
2）Suberbielle E, Sanchez PE, Kravitz AV, et al. Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-β. Nat Neurosci. 2013; 16: 613-21
|
|
|
|
|
|
3）Cirrito JR, Yamada KA, Finn MB, et al. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron. 2005; 48: 913-22
|
|
|
|
|
|
4）Cirrito JR, Kang JE, Lee J, et al. Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron. 2008; 58: 42-51
|
|
|
|
|
|
5）Roberson ED, Scearce-Levie K, Palop JJ, et al. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimerʼs disease mouse model. Science. 2007; 316: 750-4
|
|
|
|
|
|
6）Roberson ED, Halabisky B, Yoo JW, et al. Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimerʼs disease. J Neurosci. 2011; 31: 700-11
|
|
|
|
|
|
7）Cissé M, Halabisky B, Harris J, et al. Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature. 2011; 469: 47-52
|
|
|
|
|
|
8）Jin M, Shepardson N, Yang T, et al. Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci U S A. 2011; 108: 5819-24
|
|
|
|
|
|
9）Sanders DW, Kaufman SK, DeVos SL, et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron. 2014; 82: 1271-88
|
|
|
|
|
|
10）La Spada AR, Wilson EM, Lubahn DB, et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991; 352: 77-9
|
|
|
|
|
|
11）Orr HT, Chung MY, Banfi S, et al. Expansion of an unstable trinucleotide CAG repeat in spino-cerebellar ataxia type 1. Nat Genet. 1993; 4: 221-6
|
|
|
|
|
|
12）A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntingtonʼs disease chromosomes. The Huntingtonʼs Disease Collaborative Research Group. Cell. 1993; 72: 971-83
|
|
|
|
|
|
13）Imafuku I, Waragai M, Takeuchi S, et al. Polar amino acid-rich sequences bind to polyglutamine tracts. Biochem Biophys Res Commun. 1998; 253: 16-20
|
|
|
|
|
|
14）Hirabayashi M, Inoue K, Tanaka K, et al. VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ. 2001; 8: 977-84
|
|
|
|
|
|
15）Fujita K1, Nakamura Y, Oka T, A functional deficiency of TERA/VCP/p97 contributes to impaired DNA repair in multiple polyglutamine diseases. Nat Commun. 2013; 4: 1816
|
|
|
|
|
|
16）Bartolome F, Wu HC, Burchell VS, et al. Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. Neuron. 2013; 78: 57-64
|
|
|
|
|
|
17）Qi ML, Tagawa K, Enokido Y, et al. Proteome analysis of soluble nuclear proteins reveals that HMGB1/2 suppress genotoxic stress in polyglutamine diseases. Nat Cell Biol. 2007; 9: 402-14
|
|
|
|
|
|
18）Enokido Y, Tamura T, Ito H, et al. Mutant huntingtin impairs Ku70-mediated DNA repair. J Cell Biol. 2010; 189: 425-43
|
|
|
|
|
|
19）Barclay SS, Tamura T, Ito H, et al. Systems biology analysis of Drosophila in vivo screen data elucidates core networks for DNA damage repair in SCA1. Hum Mol Genet. 2014; 23:1345-64
|
|
|
|
|